- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01981226
Sonoelastographic Changes After Low Energy Extracorporeal Shock Wave Therapy (ESWT) in Plantar Fasciitis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
For patient who met the inclusion criteria, we check sonography and sonoelastography for their plantar fascias and obtain a thorough evulation questionaire for clinical symptom and pain condition and intensity in various conditions, also SF-36 questionaire first. Inform consent was done.
After the ESWT, we follow patient with questionaire and sonography/sonoelastography at 1-week, 1-month, 3-month, 6-month, 9-month, and 12-month post-ESWT time.
The colored sonoelastographic image was analysed by computer software "Image-J" with hue analysis method and relative stiffness of selected area within proximal plantar fascia wasa obtained for statistical analysis.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Taipei, Taiwan, 100
- Recruiting
- Natinal Taiwan University Hospital
-
Contact:
- Yun-yi Lin, M.D.
- Phone Number: +886972655935
- Email: doc9775c@yahoo.com.tw
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- pain for more than 6 months,poor response to the conservative treatments
- Sonography showed plantar fasciitia>4.0mm)
Exclusion Criteria:
- Acute infection of soft tissue/bone
- Malignant primary disease
- Blood coagulation disorders
- Pregnancy
- Patients with pacemaker
- foot deformity
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Extracoporeal shock wave
Extracoporeal shock wave, 3000 shots/time, once a week for 3 weeks, treatment duration:30 minutes/time, shock wave freqency:2-4Hz, energy level:0.8-1.0 mJ/mm2
|
Extracoporeal shock wave, 3000 shots/time, once a week for 3 weeks, treatment duration:30 minutes/time, shock wave freqency:2-4Hz, energy level:0.8-1.0 mJ/mm2
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Sonoelastographic changes of plantar fascia after ESWT
Time Frame: pre-treatment, 1 week, 1 month, 3 month, 6 month, 9 month, 12 month
|
pre-treatment, 1 week, 1 month, 3 month, 6 month, 9 month, 12 month
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Plantar fascia thickness
Time Frame: pre-treatment, 1 week, 1 month, 3 month, 6 month, 9 month, 12 month
|
pre-treatment, 1 week, 1 month, 3 month, 6 month, 9 month, 12 month
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Pain intensity(VAS scale)
Time Frame: pre-treatment, 1 week, 1 month, 3 month, 6 month, 9 month, 12 month
|
pre-treatment, 1 week, 1 month, 3 month, 6 month, 9 month, 12 month
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201007055R
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.